A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta -1b in patients with multiple sclerosis

OBJECTIVES: To study the safety and efficacy of vitamin D3 as an add on therapy to interferon beta -1b (IFNB) in patients with multiple sclerosis (MS). METHODS: 1 year, double blind, placebo controlled, randomised study in 66 MS patients. The primary outcomes were T2 burden of disease (BOD) on MRI s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2012-01, Vol.83 (5), p.565-571
Hauptverfasser:	Soilu-Haenninen, Merja, Aaivo, Julia, Lindstroem, Britt-Marie, Elovaara, Irina, Sumelahti, Marja-Liisa, Faerkkilae, Markus, Tienari, Pentti, Atula, Sari, Sarasoja, Taneli, Herrala, Lauri, Keskinarkaus, Irma, Kruger, Johanna, Kallio, Timo, Rocca, Maria A, Filippi, Massimo
Format:	Artikel
Sprache:	eng
Schlagworte:	25-Hydroxyvitamin D beta -Interferon Clinical trials Foot Magnetic resonance imaging Multiple sclerosis Neurosurgery Parathyroid hormone Serum levels Vitamin D Vitamin D3
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!